Pregabalin Dosing in Peritoneal Dialysis
For adults on peritoneal dialysis, pregabalin should be dosed at 25 mg once daily as a starting dose, with careful titration up to a maximum of 75 mg once daily based on tolerability and response. 1
Dosing Algorithm for Peritoneal Dialysis Patients
The FDA-approved Lyrica label provides specific guidance for patients with severe renal impairment (creatinine clearance <15 mL/min), which applies to peritoneal dialysis patients 1:
Starting Dose
- 25 mg once daily (QD)
Titration Options
- 25-50 mg once daily (low-moderate dose range)
- 50-75 mg once daily (moderate-high dose range)
- Maximum: 75 mg once daily
Key Dosing Principles
Renal clearance is critical: Pregabalin is eliminated primarily by renal excretion (approximately 90% unchanged in urine), making dose adjustment essential in dialysis patients 1. The drug's clearance is nearly proportional to creatinine clearance 2.
No supplemental dosing needed: Unlike hemodialysis patients who require supplemental doses post-dialysis, peritoneal dialysis patients do not require supplemental dosing 1. This is because peritoneal dialysis removes substantially less drug than hemodialysis, and the continuous nature of peritoneal dialysis means cumulative drug removal is already accounted for in the reduced daily dose 3.
Clinical Context and Monitoring
Start low and go slow: The evidence consistently emphasizes starting with the lowest possible dose in dialysis patients. Research demonstrates that even 100 mg post-dialysis three times weekly (equivalent to approximately 43 mg/day) provided significant benefit in hemodialysis patients with uremic pruritus 4, 5. For peritoneal dialysis, the 25 mg daily starting dose is appropriate given continuous dialysis.
Watch for neurotoxicity: Pregabalin accumulation in renal impairment can cause dose-dependent adverse effects including dizziness, somnolence, mental clouding, and rarely myoclonus 6, 7. These effects are particularly problematic in dialysis patients and can occur even without additional renal dysfunction 7.
Titration timeline: If the starting dose is tolerated after 1-2 weeks and additional efficacy is needed, increase by 25 mg increments every 1-2 weeks. Do not exceed 75 mg daily in peritoneal dialysis patients 1.
Common Pitfalls to Avoid
Do not use hemodialysis dosing: Hemodialysis patients receive supplemental doses after each session; peritoneal dialysis patients do not 1
Do not assume standard dosing applies: The typical starting dose for patients with normal renal function is 150 mg/day, which is 6-fold higher than the peritoneal dialysis starting dose 1
Do not overlook drug accumulation: Even with appropriate dosing, monitor closely for signs of drug accumulation, particularly altered mental status or movement disorders 8, 7
Do not forget medication reconciliation: A case report highlighted a peritoneal dialysis patient prescribed inappropriately high doses of both gabapentin (300 mg TID) and acyclovir at discharge, leading to a fall and hip fracture 8. Always verify dialysis status and adjust accordingly.
Evidence Strength
The dosing recommendations come directly from the FDA-approved drug label 1, which represents the highest level of prescribing authority. Supporting pharmacokinetic data demonstrates that pregabalin clearance is directly proportional to creatinine clearance, with a 50% dose reduction recommended for each 50% decrease in creatinine clearance 2. Clinical experience in dialysis populations, particularly with uremic pruritus, confirms efficacy at these reduced doses 4, 5.